(Q30406481)

English

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines (English)

1 reference

Europe PubMed Central

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

object named as

Paul T Heath

4

1 reference

Europe PubMed Central

21 June 2017

6

object named as

Andrew J Pollard

1 reference

Europe PubMed Central

21 June 2017

Matthew D Snape

object named as

Matthew D Snape

7

1 reference

Europe PubMed Central

21 June 2017

object named as

Saul N Faust

8

1 reference

Europe PubMed Central

21 June 2017

Pauline A. Waight

9

object named as

Pauline A Waight

1 reference

Europe PubMed Central

21 June 2017

Claire Waddington

12

object named as

Claire Waddington

1 reference

Europe PubMed Central

21 June 2017

Shamez N Ladhani

object named as

Shamez Ladhani

25

1 reference

Europe PubMed Central

21 June 2017

Elizabeth Miller

26

object named as

Elizabeth Miller

1 reference

Europe PubMed Central

21 June 2017

10

object named as

Katja Hoschler

1 reference

Europe PubMed Central

21 June 2017

Nick J. Andrews

1

object named as

Nick J Andrews

1 reference

Europe PubMed Central

21 June 2017

author name string

Woolf T Walker

2

1 reference

Europe PubMed Central

21 June 2017

Adam Finn

3

1 reference

Europe PubMed Central

21 June 2017

Andrew C Collinson

5

1 reference

Europe PubMed Central

21 June 2017

Liz Sheasby

11

1 reference

Europe PubMed Central

21 June 2017

Simon Kerridge

13

1 reference

Europe PubMed Central

21 June 2017

Jeremy Chalk

14

1 reference

Europe PubMed Central

21 June 2017

Amanda Reiner

15

1 reference

Europe PubMed Central

21 June 2017

Tessa John

16

1 reference

Europe PubMed Central

21 June 2017

Margaret Fletcher

17

1 reference

Europe PubMed Central

21 June 2017

Ruth Allen

18

1 reference

Europe PubMed Central

21 June 2017

Natalie Fineman

19

1 reference

Europe PubMed Central

21 June 2017

Su Wilkins

20

1 reference

Europe PubMed Central

21 June 2017

Michelle Casey

21

1 reference

Europe PubMed Central

21 June 2017

Louise Michaelis

22

1 reference

Europe PubMed Central

21 June 2017

Clarissa Oeser

23

1 reference

Europe PubMed Central

21 June 2017

Ifeanyichukwu Okike

24

1 reference

Europe PubMed Central

21 June 2017

language of work or name

0 references

publication date

27 August 2011

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

29

1 reference

Europe PubMed Central

21 June 2017

45

1 reference

Europe PubMed Central

21 June 2017

7913-7919

1 reference

Europe PubMed Central

21 June 2017

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK c

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Genetic regulation of immune responses to vaccines in early life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Disquisitions of Original Antigenic Sin. I. Evidence in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.076

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.08.076

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30406481&oldid=1907884141"